Media release
From: AAASScience Advances
Shedding light on reports of unexpected menstrual bleeding after SARS-CoV-2 vaccination, a web-based survey of more than 39,000 adult respondents found that 42% of those with regular menstrual cycles bled more heavily than usual after vaccination. The study suggests that certain groups were more likely to experience heavy post-vaccination bleeding, including older premenopausal respondents, Hispanic or Latinx respondents, those who had previously been pregnant or had given birth, and those with conditions including endometriosis and polycystic ovary syndrome (PCOS). In addition, some respondents who typically do not menstruate, including those on long-acting reversible contraceptives or gender-affirming hormones and those who have experienced menopause, reported breakthrough bleeding. “Generally, changes to menstrual bleeding are not uncommon or dangerous, yet attention to these experiences is necessary to build trust in medicine,” Katharine Lee and colleagues write, noting the long history of medical misogyny and gaslighting experienced by people who menstruate. Since vaccine trial protocols do not usually monitor beyond 7 days post-vaccination and follow-up communications do not inquire about menstruation, SARS-CoV-2 vaccine manufacturers have been unable to address reports of unexpected menstrual bleeding following vaccination. Medical experts’ dismissal of a possible connection between the vaccines and menstrual changes has fueled greater concerns, leading vaccine-hesitant and anti-vaccine individuals and organizations to conflate these short-term changes with long-term fertility harm. To address concerns about how SARS-CoV-2 vaccines could affect menstruation, Lee et al. surveyed 39,129 fully vaccinated individuals (before boosters became available) who had not contracted COVID-19. Of the respondents, about 90% identified as women only, while 9.1% were categorized as gender diverse. After analyzing their first 3 months of data, the researchers found that a significant proportion of respondents experienced some form of increased menstrual bleeding. They noted that many respondents observed these changes beginning more than a week after vaccination, which extends beyond the period when adverse symptom reporting is closely monitored during trials.
Expert Reaction
These comments have been collated by the Science Media Centre to provide a variety of expert perspectives on this issue. Feel free to use these quotes in your stories. Views expressed are the personal opinions of the experts named. They do not represent the views of the SMC or any other organisation unless specifically stated.